UBS Group’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7K | Sell |
29,575
-18,788
| -39% | -$7.44K | ﹤0.01% | 7456 |
|
|
2025
Q1 | $16.8K | Sell |
48,363
-2,497
| -5% | -$866 | ﹤0.01% | 7037 |
|
|
2024
Q4 | $30.1K | Buy |
50,860
+39,908
| +364% | +$23.6K | ﹤0.01% | 6376 |
|
|
2024
Q3 | $19.3K | Sell |
10,952
-17,471
| -61% | -$30.8K | ﹤0.01% | 6189 |
|
|
2024
Q2 | $38.9K | Sell |
28,423
-18,904
| -40% | -$25.9K | ﹤0.01% | 5735 |
|
|
2024
Q1 | $163K | Sell |
47,327
-464
| -1% | -$1.6K | ﹤0.01% | 4833 |
|
|
2023
Q4 | $118K | Buy |
47,791
+25,173
| +111% | +$61.9K | ﹤0.01% | 4902 |
|
|
2023
Q3 | $38.5K | Sell |
22,618
-1,977
| -8% | -$3.36K | ﹤0.01% | 5331 |
|
|
2023
Q2 | $73.8K | Buy |
+24,595
| New | +$73.8K | ﹤0.01% | 5176 |
|
|
2023
Q1 | – | Sell |
-3,071
| Closed | -$25.3K | – | 8475 |
|
|
2022
Q4 | $25.3K | Sell |
3,071
-2,513
| -45% | -$20.7K | ﹤0.01% | 6237 |
|
|
2022
Q3 | $43K | Buy |
+5,584
| New | +$43K | ﹤0.01% | 5418 |
|
|
2022
Q1 | – | Sell |
-70,994
| Closed | -$1.39M | – | 9156 |
|
|
2021
Q4 | $1.39M | Buy |
70,994
+31,441
| +79% | +$617K | ﹤0.01% | 3174 |
|
|
2021
Q3 | $1.16M | Buy |
39,553
+37,289
| +1,647% | +$1.1M | ﹤0.01% | 3137 |
|
|
2021
Q2 | $96K | Sell |
2,264
-264
| -10% | -$11.2K | ﹤0.01% | 4869 |
|
|
2021
Q1 | $129K | Buy |
2,528
+2,022
| +400% | +$103K | ﹤0.01% | 4780 |
|
|
2020
Q4 | $17K | Buy |
+506
| New | +$17K | ﹤0.01% | 6032 |
|